DL
ALXN

Delta Lloyd’s Alexion Pharmaceuticals ALXN Stock Holding History

Delta Lloyd’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-15,677
Closed -$1.92M – 636
2016
Q3 		$1.92M Hold
15,677
– – 0.06% 247
2016
Q2 		$1.83M Hold
15,677
– – 0.06% 238
2016
Q1 		$2.18M Sell
15,677
-599
-4% -$88K 0.07% 203
2015
Q4 		$3.1M Buy
16,276
+59
+0.4% +$10.3K 0.11% 151
2015
Q3 		$2.54M Buy
16,217
+2,458
+18% +$448K 0.08% 193
2015
Q2 		$2.49M Buy
13,759
+5,088
+59% +$878K 0.08% 195
2015
Q1 		$1.5M Hold
8,671
– – 0.05% 222
2014
Q4 		$1.6M Hold
8,671
– – 0.05% 213
2014
Q3 		$1.44M Buy
8,671
+978
+13% +$161K 0.01% 216
2014
Q2 		$1.2M Buy
7,693
+991
+15% +$156K 0.04% 229
2014
Q1 		$1.02M Sell
6,702
-190
-3% -$30.2K 0.03% 231
2013
Q4 		$916K Sell
6,892
-63,398
-90% -$7.61M 0.03% 240
2013
Q3 		$8.16M Sell
70,290
-15,950
-18% -$1.75M 0.31% 69
2013
Q2 		$7.96M Buy
+86,240
New +$8.31M 0.31% 71

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return